SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Do mid-size CROs have business model problems? One CEO thinks so

Squeezed by the pressure of shorter deadlines and higher quality expectations, as well as by competition from larger peers, mid-size CROs may need to think more about innovation to stay ahead, a CEO of a mid-size CRO told us.

News from CPHI Paris

Doctors ask for quick-dissolve meds to stop in-patient cheating

Patients receiving court-ordered treatment can be stopped from secretly spitting out their medicines by formulations which dissolve quickly in the mouth.

Parexel pushes further into UK with new grants, Nottingham office

Little more than a week after purchasing the UK RTSM provider ClinIntel , Parexel has secured new office space in Nottingham, UK and won grants totalling £1m ($1.6m). 

Sellas signs up PPD as a preferred partner

Swiss-based Sellas Life Sciences Group has signed a definitive master service agreement with CRO Pharmaceutical Product Development (PPD) to advance and expand clinical and regulatory development.

NEWS FROM CPHI

Polymers make you go faster, greener, say BASF and Colorcon

BASF, one of the world’s largest chemical companies, has chosen Colorcon to distribute its Kollicoat Immediate Release (IR) tablet coatings.

NEWS FROM CPHI

A bitter pill to swallow: young people dislike tablets more than old

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

Spotlight

ex-RPS CIO drops lawsuit after settling wrongful dismissal case

ex-RPS CIO drops wrongful dismissal lawsuit and allegations the CRO unlawfully stored applicant data

An ex RPS employee who claimed he was sacked after discovering the CRO was unlawfully storing potential...

Consort Medical to buy Aesica for £230m
update

Consort Medical cites growing Bespak as driver for £230m Aesica acquisition

Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.

Medidata hit by $4.8m wire fraud, but says customer data is safe

Medidata hit by $4.8m wire fraud, but says customer clinical trial data is safe

Fraudsters who hoodwinked Medidata Solutions into transferring $4.8m to an "overseas" account this month did not access...

EMA opens investigation into India’s GVK Bio over ECG falsifications
Update

EMA opens investigation into India’s GVK Bio over ECG falsifications

At the request of the European Commission, the EMA (European Medicines Agency) announced Friday that it would...

AstraZeneca brings IT services in-house with new Indian facility

AstraZeneca brings IT services in-house with new Indian facility

The opening of a global IT centre in India will bring services back in-house, but AstraZeneca says...

Ukraine still attracting international trials according to new study

Ukraine still attracting Quintiles, PPD, Icon, Parexel and INC says study

Political instability in Ukraine has not diminished international drug industry desire to conduct clinical trials there according...